ARCHIVES

ODAC Reviews Post-Marketing Studies for Eight Indications

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | March 21, 2003

Download PDF Visit The Full Archive

Related Articles

NIH To Site Visit Animal Facilities

March 18, 1983

FDA Revises Package Insert, Seeks To Limit Product Liability Suits In State Courts.

January 20, 2006

New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years

October 26, 2012

$5 Million Lift Raises Payline From 180 to 185

May 21, 1982

Schering to Pay $435M to Settle Federal Charges.

January 26, 2007

Radiation Oncologists Form New College To Address Identity

April 12, 1991